CTT Pharmaceutical Holdings, Inc. CTTH
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 0.00 | 7.10K | 15.40K | -- | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 0.00 | 7.10K | 15.40K | -- | -- |
|
|
|||||
| Total Current Assets | 0.00 | 7.10K | 15.40K | -- | -- |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 63.10K | 69.10K | 66.50K | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.30K | -- | 4.30K | -- | -- |
| Total Assets | 67.40K | 76.20K | 86.20K | -- | -- |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 19.40K | 18.80K | 18.80K | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 21.90K | 16.10K | 12.20K | -- | -- |
| Total Other Current Liabilities | 21.90K | 16.10K | 12.20K | -- | -- |
| Total Current Liabilities | 41.40K | 34.90K | 31.00K | -- | -- |
|
|
|||||
| Total Current Liabilities | 41.40K | 34.90K | 31.00K | -- | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 19.40K | 18.80K | 18.80K | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 41.40K | 34.90K | 31.00K | -- | -- |
|
|
|||||
| Common Stock & APIC | 7.68M | 7.68M | 7.61M | -- | -- |
| Retained Earnings | -7.65M | -7.64M | -7.55M | -- | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 26.00K | 41.30K | 55.20K | -- | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 26.00K | 41.30K | 55.20K | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 26.00K | 41.30K | 55.20K | -- | -- |
|
|
|||||